Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 6/20 | 0.42 |
| ▸ | CA2 | P00918 | 6/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | LOX | P28300 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10410092 | 0.83 | TDP1 (0.53) | TDP1CA1CA2LMNA | |
| SCHEMBL24330535 | 0.82 | TDP1 (0.53) | TDP1LMNATSHRMAPK1RAB9A | |
| SCHEMBL16784390 | 0.81 | TDP1 (0.39) | TDP1CA1CA2KDM4EALDH1A1 | |
| SCHEMBL397968 | 0.81 | CYP4F2 (0.51) | CA1CA2KDM4EALDH1A1LMNA | |
| SCHEMBL7455946 | 0.80 | LMNA (0.53) | TDP1ALDH1A1LMNATSHRRAB9A | |
| SCHEMBL7457332 | 0.80 | LMNA (0.53) | TDP1ALDH1A1LMNATSHRRAB9A | |
| SCHEMBL14659582 | 0.79 | ALDH1A1 (0.60) | TDP1CA1CA2KDM4EALDH1A1 | |
| SCHEMBL10674511 | 0.79 | TDP1 (0.45) | TDP1CA1CA2ALDH1A1LMNA | |
| SCHEMBL12176926 | 0.78 | HSPD1 (0.55) | TDP1CA1CA2ALDH1A1TSHR | |
| SCHEMBL14666797 | 0.78 | LMNA (0.62) | KDM4ELMNARAB9ASMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9284295-B2 | Tetrahydrobenzothiophene compound | ASTELLAS PHARMA INC. (JP) | 2016-03-15 | — | — | US | disclosed |
| US-9284295-B2 | Tetrahydrobenzothiophene compound | ASTELLAS PHARMA INC. (JP) | 2016-03-15 | — | — | US | disclosed |
| EP-2565190-B1 | TETRAHYDROBENZOTHIOPHENE COMPOUND | ASTELLAS PHARMA INC (JP) | 2015-06-03 | — | — | EP | disclosed |
| US-20140329802-A1 | TETRAHYDROBENZOTHIOPHENE COMPOUND | ASTELLAS PHARMA INC. (JP) | 2014-11-06 | — | — | US | disclosed |
| US-20140329802-A1 | TETRAHYDROBENZOTHIOPHENE COMPOUND | ASTELLAS PHARMA INC. (JP) | 2014-11-06 | — | — | US | disclosed |
| US-20140329802-A1 | TETRAHYDROBENZOTHIOPHENE COMPOUND | ASTELLAS PHARMA INC. (JP) | 2014-11-06 | — | — | US | disclosed |
| US-8729068-B2 | Tetrahydrobenzothiophene compound | ASTELLAS PHARMA INC. (JP) | 2014-05-20 | — | — | US | disclosed |
| US-8729068-B2 | Tetrahydrobenzothiophene compound | ASTELLAS PHARMA INC. (JP) | 2014-05-20 | — | — | US | disclosed |
| US-8729068-B2 | Tetrahydrobenzothiophene compound | ASTELLAS PHARMA INC. (JP) | 2014-05-20 | — | — | US | disclosed |
| EP-2565190-A1 | TETRAHYDROBENZOTHIOPHENE COMPOUND | Astellas Pharma Inc. (JP) | 2013-03-06 | — | — | EP | disclosed |
| US-20130053369-A1 | TETRAHYDROBENZOTHIOPHENE COMPOUND | ASTELLAS PHARMA INC. (JP) | 2013-02-28 | — | — | US | disclosed |
| US-20130053369-A1 | TETRAHYDROBENZOTHIOPHENE COMPOUND | ASTELLAS PHARMA INC. (JP) | 2013-02-28 | — | — | US | disclosed |
| US-20130029973-A1 | TETRAHYDROBENZOTHIOPHENE COMPOUND | ASTELLAS PHARMA INC. (JP) | 2013-01-31 | — | — | US | disclosed |
| US-20130029973-A1 | TETRAHYDROBENZOTHIOPHENE COMPOUND | ASTELLAS PHARMA INC. (JP) | 2013-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140329802-A1 | TETRAHYDROBENZOTHIOPHENE COMPOUND | SLC34A2, SLC34A1, SLC10A2 | TDP1 2326/4885CA1 2988/4885CA2 350/4885 |
| US-20130029973-A1 | TETRAHYDROBENZOTHIOPHENE COMPOUND | SLC34A2, SLC10A2, SLC34A1 | TDP1 1886/4885CA1 2065/4885CA2 272/4885 |
| US-20130053369-A1 | TETRAHYDROBENZOTHIOPHENE COMPOUND | SLC34A2, SLC34A1, SLC10A2 | TDP1 2326/4885CA1 2988/4885CA2 350/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.